Ambrosch A, Domroese U, Westphal S, Dierkes J, Augustin W, Neumann K H, Luley C
Department of Pathobiochemistry, University Hospital of Magdeburg, Germany.
Kidney Int. 1998 Aug;54(2):608-17. doi: 10.1046/j.1523-1755.1998.00024.x.
This study focused on the effects of hemodialysis on the atherogenic properties of low density lipoprotein (LDL) in patients with end-stage renal disease (ESRD). The impact of cholesterol ester transfer protein (CETP) activity and lipolysis on LDL composition, particularly the changes during hemodialysis, was investigated.
Blood was drawn from 15 normotriglyceridemic (NTG) and 15 hypertriglyceridemic patients [HTG; triglycerides (TG) < 2.2 mmol/liter] before hemodialysis, during (1.5 hr after the beginning of anticoagulation) and at the end of treatment. In each sample, lipid values and CETP activity were measured. LDL was prepared and characterized by its components and diameters (2 to 16% PAGGE). To investigate the functional properties of LDL, fractions obtained from NTG and HTG patients were incubated with human skin fibroblasts and a cell line of murine macrophages (P388), and cholesterol ester formation rates were measured.
In comparison to LDL from NTG patients at baseline, HTG-LDL were enriched in triglycerides (P < 0.02), depleted in cholesterol proportion (P < 0.01) and small in size (P < 0.001). These LDL induced the cholesterol esterification rates (50 micrograms/mL LDL-protein) in a twofold greater unsaturation in macrophages when compared to LDL from NTG patients (P < 0.04). The rates in fibroblasts were reduced by approximately half (P < 0.05). During hemodialysis, LDL were decreased in size (P < 0.001) and depleted in TG (P < 0.01), particularly in the hypertriglyceridemic state. Although CETP activity increased during hemodialysis (P < 0.001), the cholesterol content remained unchanged. When HTG-LDL obtained during hemodialysis were incubated with cells, esterification rates particularly in macrophages were markedly accelerated in comparison to the unmodified lipoprotein at baseline (P < 0.05).
LDL from HTG patients with ESRD was TG-enriched, CH-depleted and smaller in size. As the intracellular esterification rates induced by LDL were related to the cellular uptake, these LDL were a superior substrate for murine macrophages with the tendency of intracellular accumulation, and an inferior substrate for fibroblasts suggesting a decreased uptake by the specific receptor pathway. TG-depletion of LDL during hemodialysis, particularly in HTG patients due to a lipase-mediated TG-hydrolysis, increased these effects in macrophages. We suggest that the alterations of LDL that occur during repeated hemodialysis in vivo could contribute to the high prevalence of premature atherosclerosis found in HTG patients with ESRD.
本研究聚焦于血液透析对终末期肾病(ESRD)患者低密度脂蛋白(LDL)致动脉粥样硬化特性的影响。研究了胆固醇酯转运蛋白(CETP)活性和脂解作用对LDL组成的影响,特别是血液透析过程中的变化。
在血液透析前、透析期间(抗凝开始后1.5小时)和治疗结束时,从15名正常甘油三酯血症(NTG)患者和15名高甘油三酯血症患者[HTG;甘油三酯(TG)<2.2 mmol/升]中采集血液。在每个样本中,测量血脂值和CETP活性。制备LDL并通过其成分和直径(2%至16%聚丙烯酰胺凝胶电泳)进行表征。为了研究LDL的功能特性,将从NTG和HTG患者获得的组分与人皮肤成纤维细胞和小鼠巨噬细胞系(P388)一起孵育,并测量胆固醇酯形成率。
与基线时NTG患者的LDL相比,HTG-LDL富含甘油三酯(P<0.02),胆固醇比例降低(P<0.01)且尺寸较小(P<0.001)。与NTG患者的LDL相比,这些LDL在巨噬细胞中诱导的胆固醇酯化率(50微克/mL LDL蛋白)的不饱和度增加了两倍(P<0.04)。成纤维细胞中的酯化率降低了约一半(P<0.05)。在血液透析期间,LDL尺寸减小(P<0.001)且TG减少(P<0.01),特别是在高甘油三酯血症状态下。尽管血液透析期间CETP活性增加(P<0.001),但胆固醇含量保持不变。当将血液透析期间获得的HTG-LDL与细胞孵育时,与基线时未修饰的脂蛋白相比,特别是在巨噬细胞中的酯化率明显加快(P<0.05)。
ESRD的HTG患者的LDL富含TG、CH减少且尺寸较小。由于LDL诱导的细胞内酯化率与细胞摄取有关,这些LDL是小鼠巨噬细胞的优质底物,具有细胞内积累的倾向,而成纤维细胞的劣质底物表明通过特异性受体途径的摄取减少。血液透析期间LDL的TG消耗,特别是在HTG患者中由于脂肪酶介导的TG水解,增加了巨噬细胞中的这些作用。我们认为,体内反复血液透析期间发生的LDL改变可能导致ESRD的HTG患者中过早动脉粥样硬化的高患病率。